STAAR Surgical appoints Warren Foust as President and CEO, Deborah Andrews as EVP/CFO

STAAR SURGICAL CO

Warren Foust appointed President and CEO and Board member effective August 4, 2026; previously COO and Interim Co-CEO.
Deborah Andrews appointed EVP, continues as CFO; she served as Interim Co-CEO since February 2026.
Foust receives $730k base salary, 100% target bonus, and equity grants including performance options with $50/$75/$100 stock price hurdles.
Foust joined STAAR in April 2023; prior role was Worldwide President at Johnson & Johnson Vision Surgical.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Warren Foust

President and Chief Executive Officer

STAA · STAAR SURGICAL CO

Effective: 2026-08-04
Filed: August 6, 2026, 11:04 AM ET

On August 4, 2026, STAAR Surgical Company (the “Company” or “STAAR”) announced that the Company’s Board of Directors (the “Board”) appointed Warren Foust as President and Chief Executive Officer (“CEO”) and new member of the Board, effective August 4, 2026 (the “Effective Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Warren Foust was appointed as President and Chief Executive Officer at STAAR SURGICAL CO.

Action: appointed
Role: President and Chief Executive Officer

Exact text from the filing

On August 4, 2026, STAAR Surgical Company (the “Company” or “STAAR”) announced that the Company’s Board of Directors (the “Board”) appointed Warren Foust as President and Chief Executive Officer (“CEO”) and new member of the Board, effective August 4, 2026 (the “Effective Date”).

View on SEC.gov

STAAR SURGICAL CO filing history →

Source: SEC EDGAR

accession 0001193125-26-337197

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.